1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Diagnostics Focus JULY 2015

Diagnostics Focus JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Increased Targeting Will Lead To Super Niche Cancer Markets
Industry Brief - Roche To Provide HIV Diagnostic Solutions To Global Fund
Industry Brief - Hitachi/QIAGEN Enter Molecular Testing Collaboration
Industry Trend Analysis - Virtual Diagnostic Testing Adds Scale To HealthTap's Service
Industry Brief - GenomeDx Signs Exclusive Marketing Deal For Decipher In Israel/Palestine
Industry Brief - Cancer Genetics Teams Up With ICON's Laboratory Services
Industry Brief - Seegene To Develop Molecular Diagnostic Assays For QIAGEN's Rotor-Gene Q
Industry Trend Analysis - Sequenom Appeal Failure Implies Wider Market Changes
Industry Brief - Quintiles/Quest Launch Q2 Solutions
Industry Brief - Eurofins To Acquire 75% Stake In Emory Genetics Laboratory
Industry Brief - Quest To Acquire MemorialCare Health System's Laboratory Outreach Service Business
Industry Trend Analysis - Natera's IPO Signals Shift In NIPT Market
Industry Brief - Diagnostics 510(k) Clearances - June 2015
Industry Brief - Vitros Chemistry Products HbA1c Reagent Kit FDA-Cleared
Industry Brief - Asuragen Launches Quantidex Pan Cancer Kit
Industry Brief - Roche Launches Cardiac PoC Troponin T Test
Industry Brief - 4Kscore Test Recommended In NCCN Prostate Cancer Early Detection Guidelines
Industry Brief - PathGroup Offers Cancer-Specific SmartGenomics Testing In US
Industry Brief - CellDetect Non-Invasive BC Test CE-Marked
Industry Brief - Novacyt Offers Molecular HPV Service For NOVAprep Customers
Industry Brief - SkylineDx Launches MMProfiler Assay For MM Prognosis
Industry Brief - Solana Molecular System/Group A Strep Assay FDA-Cleared
Industry Brief - Idylla KRAS Mutation Test Launched In Europe
Industry Brief - Biomerica's Clinical Laboratory Products Approved In Brazil
Industry Brief - Theranos' HSV-1 IgG Test/System Gain US Marketing Green Light
Industry Brief - Biocept Launches Blood-Based FGFr1 Test Menu
Industry Brief - Architect Galectin-3 Assay Available In US
Industry Brief - Great Basin's GBS Test Now Available In US
Industry Trend Analysis - Iressa's US Return Will Be Further Enhanced By Liquid Biopsy
Industry Brief - LamdaGen Granted EU Patent Allowance
Industry Brief - ACD Raises Funds To Accelerate Commercialisation Of New Technology Platforms
Industry Brief - Firefly Dx Pathogen Detection System Successful In 12 Different Assays
Industry Brief - Breath Test Developed To Detect Oesophageal/Gastric cancers
Industry Brief - Xagenic Raises Funds To Support Xagenic X1 Platform
Industry Brief - Natera Selected For TRACERx Study Of LC Heterogeneity Using ctDNA
Industry Brief - Cellsearch System Shows Feasibility Of Liquid Biopsy In Breast Cancer
Industry Brief - Diagnostic Conferences - July 2015

Table Of Contents

Diagnostics Focus JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in Australia - Forecast

  • February 2017
    4 pages
  • Cancer  

    Ovarian Cancer  

  • Australia  

    Oceania  

View report >

Cancer Statistics in the UK

  • February 2017
    11 pages
  • Cancer  

  • United Kingdom  

    Australia  

    Denmark  

View report >

Cancer and Breast Cancer Statistics in Switzerland

  • February 2017
    138 pages
  • Cancer  

    Breast Cancer  

    Obesity  

  • Switzerland  

View report >

Cancer Statistics

7 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.